Welcome to LookChem.com Sign In|Join Free
  • or
1,6-Diazaspiro[3.4]octane-1-carboxylic acid, 5-oxo-6-(phenylMethyl)-, 1,1-diMethylethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1148044-28-3

Post Buying Request

1148044-28-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1148044-28-3 Usage

Explanation

The full chemical name of the compound, which describes its structure and functional groups.

Explanation

The molecular formula represents the number of carbon (C), hydrogen (H), nitrogen (N), and oxygen (O) atoms in the compound.

Explanation

The molecular weight is the sum of the atomic weights of all the atoms in the molecule.

Explanation

These functional groups are present in the compound and contribute to its chemical properties and reactivity.

Explanation

The compound is derived from a spiro-alkaloid, which is a type of organic compound with a spiro-connected nitrogen-containing ring.

Explanation

The compound is primarily used as a building block in the synthesis of various pharmacologically active molecules, contributing to drug development.

Explanation

The presence of the 1,1-dimethylethyl ester group improves the solubility of the compound, making it more suitable for chemical reactions and drug development.

Explanation

The ester group also contributes to the stability of the compound, making it a more reliable building block for the synthesis of active pharmaceutical ingredients.

Explanation

The unique structure and properties of the compound make it a valuable candidate for research and development of new drugs with various therapeutic applications.

Explanation

The compound's unique structure and potential applications in drug development make it an important chemical for researchers to study and utilize in the creation of novel therapeutic agents.

Molecular Weight

299.38 g/mol

Functional Groups

Carboxylic acid, ester, amide, and aromatic ring

Structure

Spiro-alkaloid derivative

Application

Pharmaceutical intermediate

Solubility

Enhanced by the 1,1-dimethylethyl ester group

Stability

Improved by the 1,1-dimethylethyl ester group

Pharmacological Properties

Potential applications in the development of new drugs

Research Value

Valuable for research and drug development purposes

Check Digit Verification of cas no

The CAS Registry Mumber 1148044-28-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,8,0,4 and 4 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1148044-28:
(9*1)+(8*1)+(7*4)+(6*8)+(5*0)+(4*4)+(3*4)+(2*2)+(1*8)=133
133 % 10 = 3
So 1148044-28-3 is a valid CAS Registry Number.

1148044-28-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methyl-2-propanyl 6-benzyl-5-oxo-1,6-diazaspiro[3.4]octane-1-ca rboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1148044-28-3 SDS

1148044-28-3Upstream product

1148044-28-3Downstream Products

1148044-28-3Relevant academic research and scientific papers

Preparation and characterization of N-(3-pyridinyl) spirocyclic diamines as ligands for nicotinic acetylcholine receptors

Sippy, Kevin B.,Anderson, David J.,Bunnelle, William H.,Hutchins, Charles W.,Schrimpf, Michael R.

scheme or table, p. 1682 - 1685 (2009/11/30)

Several N-pyridin-3-yl spirobicyclic diamines, designed as conformationally restricted analogs of tebanicline (ABT-594), were synthesized as novel ligands for nicotinic acetylcholine receptors (nAChR). The spirocyclic compounds exhibited weaker binding affinity, than other constrained analogs in accord with a pharmacophore model. Nevertheless, some (1a, 1b) possessed (partial) agonist potencies comparable to nicotine at the α4β2 subtype, but with greatly improved selectivity relative to the α3β4* nAChR.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1148044-28-3